Collegium Pharmaceutical, Inc. (COLL) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Collegium Pharmaceutical, Inc. · Health Care · ref. ETF XLV · 55 calls · price $21.53
What the company does: Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
📈 Collegium Pharmaceutical, Inc. (COLL) stock price
$21.53-33.1% over range
Oct 14, 25low $21.53 · high $49.84Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 6 analysts
📊 JPI status : Collegium Pharmaceutical, Inc. is currently in 🎯 JPI Fair n°5.
🎯 COLL price target & analyst consensus — price $21.53
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$50+132.2%
Median target · of 6 targets$47+118.3%
Lowest target · 1 firm of 6$43+99.7%
Current price$21.53
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
6100%
$43 ↔ $50
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Leerink Partners — 64% of its targets hit on this sector (11 calls tested). It aims for $45 (+109 %), call made on September 10, 2026, maturing on September 10, 2027 (34 d ago).
The 1 reliable analyst
$45+109 %
The 5 other firms
$48+123 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $45 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy583%
Hold117%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 COLL price target all
All 55 calls, one by one, with our verdict on each firm.
→ See all 55 targets, analyst by analyst💡 The best analysts on COLL most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in COLL? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Collegium Pharmaceutical, Inc.? The JPI assistant answers using our backtest data.
✅ Historical analyst reliability on COLL
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Needham ↗ | 71% | +20.6% | 21 |
| Piper Sandler ↗ | 67% | +1.0% | 3 |
| HC Wainwright & Co. ↗ | 56% | +10.2% | 9 |
| Cantor Fitzgerald ↗ | 50% | -4.6% | 4 |
| Truist Securities ↗ | 33% | -10.3% | 3 |
| Jefferies ↗ | 0% | -4.5% | 2 |
📊 What $1,000 invested in Collegium Pharmaceutical, Inc. would be worth › open the full page
In short — $1,000 invested in Collegium Pharmaceutical, Inc. 10 years ago would be worth $1,273 today, i.e. +2%/yr on average. Best year: 2025 (+62%), worst: 2016 (-43%). Price performance, excluding dividends.
If I'd invested $1,000 in Collegium Pharmaceutical, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,222 | +22% |
| 3 years ago | $1,509 | +51% |
| 5 years ago | $1,748 | +75% |
Return by year (Collegium Pharmaceutical, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -24% | $756 (-24%) |
| 2025 | +62% | $1,222 (+22%) |
| 2024 | -7% | $1,138 (+14%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Collegium Pharmaceutical, Inc.
Loading news…
📋 All analyst calls on COLL
Filtered on — · ✕ show all
Oppenheimer ↗
Sep 23, 26
▲ Outperform · 🎯$50
Price at call : $22.45 — upside +123%
Today : $21.53 — upside +132%
🎯 on COLL : no call matured yet · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Sep 23, 27
matures : Sep 23, 27
Truist Securities ↗
Sep 9, 26
▲ Buy · 🎯$49
Price at call : $22.92 — upside +114%
Today : $21.53 — upside +128%
🎯 on COLL : 33% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Sep 9, 27
matures : Sep 9, 27
Leerink Partners ↗
Sep 9, 26
▲ Outperform · 🎯$45
Price at call : $22.92 — upside +96%
Today : $21.53 — upside +109%
🎯 on COLL : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Sep 9, 27
matures : Sep 9, 27
▲ Overweight · 🎯$48
Price at call : $27.54 — upside +74%
Today : $21.53 — upside +123%
🎯 on COLL : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
Piper Sandler ↗
Aug 7, 26
■ Neutral neutral · not a buy · 🎯$43
Price at call : $27.2 — gap to target +58%
Today : $21.53 — gap to target +100%
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Buy · 🎯$46
Price at call : $29.47 — upside +56%
Today : $21.53 — upside +114%
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
HC Wainwright & Co. ↗
Mar 20, 26
▲ Buy · 🎯$60
Price at call : $35.44 — upside +69%
Today : $21.53 — upside +179%
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Mar 20, 27
matures : Mar 20, 27
▲ Buy · 🎯$56
Price at call : $36.3 — upside +54%
Today : $21.53 — upside +160%
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Mar 19, 27
matures : Mar 19, 27
See the other 47 calls, newest to oldest
▲ Buy · 🎯$54
Price at call : $41.67 — upside +30%
Today : $21.53 — upside +151%
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Overweight · 🎯$56
Price at call : $48.15 — upside +16%
Today : $21.53 — upside +160%
🎯 on COLL : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
HC Wainwright & Co. ↗
Jan 9, 26
▲ Buy · 🎯$60
Price at call : $45.54 — upside +32%
Today : $21.53 — upside +179%
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Buy · 🎯$56
Price at call : $48.78 — upside +15%
Today : $21.53 — upside +160%
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
▲ Overweight · 🎯$58
Price at call : $48.86 — upside +19%
Today : $21.53 — upside +169%
🎯 on COLL : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Truist Securities ↗
Nov 7, 25
▲ Buy · 🎯$48
Price at call : $43.53 — upside +10%
Today : $21.53 — upside +123%
🎯 on COLL : 33% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
HC Wainwright & Co. ↗
Nov 7, 25
▲ Buy · 🎯$46
Price at call : $42.3 — upside +9%
Today : $21.53 — upside +114%
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$46
Price at call : $35.41 — upside +30%
Today : $21.53 — upside +114%
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
Piper Sandler ↗
May 9, 25
■ Neutral neutral · not a buy · 🎯$37
Price at call : $29.56 — gap to target +25%
Today : $21.53 — gap to target +72%
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : May 9, 26
matures : May 9, 26
▲ Buy · 🎯$46
Price at call : $26.37 — upside +74%
Today : $21.53 — upside +114%
Expected +74% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+33.7%
stock +34% · XLV +8%
matured Apr 9, 26
HC Wainwright & Co. ↗
Mar 24, 25
▲ Buy · 🎯$50
Price at call : $30.56 — upside +64%
Today : $21.53 — upside +132%
Expected +64% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+8.7%
stock +9% · XLV -2%
matured Mar 24, 26
Piper Sandler ↗
Feb 4, 25
■ Neutral neutral · not a buy · 🎯$36
Price at call : $30.93 — gap to target +16%
Today : $21.53 — gap to target +67%
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Feb 4, 26
matures : Feb 4, 26
▲ Buy · 🎯$46
Price at call : $32.91 — upside +40%
Today : $21.53 — upside +114%
Expected +40% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+46.3%
stock +46% · XLV +13%
matured Jan 10, 26
HC Wainwright & Co. ↗
Jan 10, 25
▲ Buy · 🎯$50
Price at call : $32.91 — upside +52%
Today : $21.53 — upside +132%
Expected +52% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+46.3%
stock +46% · XLV +13%
matured Jan 10, 26
Piper Sandler ↗
Oct 11, 24
■ Neutral neutral · not a buy · 🎯$37
Price at call : $38 — gap to target -3%
Today : $21.53 — gap to target +72%
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Oct 11, 25
matures : Oct 11, 25
HC Wainwright & Co. ↗
Sep 5, 24
▲ Buy · 🎯$50
Price at call : $37.62 — upside +33%
Today : $21.53 — upside +132%
Expected +33% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+1.9%
stock +2% · XLV -11%
matured Sep 5, 25
Piper Sandler ↗
Aug 9, 24
■ Neutral neutral · not a buy · 🎯$37
Price at call : $35.62 — gap to target +4%
Today : $21.53 — gap to target +72%
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Aug 9, 25
matures : Aug 9, 25
Truist Securities ↗
Aug 9, 24
▲ Buy · 🎯$42
Price at call : $35.5 — upside +18%
Today : $21.53 — upside +95%
Expected +18% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 33% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+1.8%
stock +2% · XLV -13%
matured Aug 9, 25
■ Hold neutral · not a buy
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Aug 9, 25
matures : Aug 9, 25
HC Wainwright & Co. ↗
Jul 30, 24
▲ Buy · 🎯$47
Price at call : $38.6 — upside +22%
Today : $21.53 — upside +118%
Expected +22% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-20.5%
stock -20% · XLV -11%
matured Jul 30, 25
■ Hold neutral · not a buy
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jul 30, 25
matures : Jul 30, 25
▲ Buy · 🎯$44
Price at call : $33.31 — upside +32%
Today : $21.53 — upside +104%
Expected +32% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
-8.6%
stock -9% · XLV -9%
matured Jun 7, 25
■ Hold neutral · not a buy
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : May 10, 25
matures : May 10, 25
Piper Sandler ↗
May 10, 24
■ Neutral neutral · not a buy · 🎯$39
Price at call : $31.5 — gap to target +24%
Today : $21.53 — gap to target +81%
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : May 10, 25
matures : May 10, 25
▲ Buy · 🎯$40
Price at call : $36.39 — upside +10%
Today : $21.53 — upside +86%
Expected +10% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-27.7%
stock -28% · XLV -3%
matured Apr 11, 25
Truist Securities ↗
Feb 26, 24
▲ Buy · 🎯$40
Price at call : $36.56 — upside +9%
Today : $21.53 — upside +86%
Expected +9% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 33% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-21.2%
stock -21% · XLV +1%
matured Feb 25, 25
Piper Sandler ↗
Feb 23, 24
▲ Overweight · 🎯$39
Price at call : $36.56 — upside +7%
Today : $21.53 — upside +81%
Expected +7% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
-20.2%
stock -20% · XLV +0%
matured Feb 22, 25
▲ Buy · 🎯$40
Price at call : $32.84 — upside +22%
Today : $21.53 — upside +86%
Expected +22% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-5.0%
stock -5% · XLV +4%
matured Feb 1, 25
▲ Buy · 🎯$40
Price at call : $32.3 — upside +24%
Today : $21.53 — upside +86%
Expected +24% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-11.4%
stock -11% · XLV -0%
matured Jan 3, 25
Truist Securities ↗
Jan 4, 24
▲ Buy · 🎯$37
Price at call : $32.3 — upside +15%
Today : $21.53 — upside +72%
Expected +15% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 33% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-11.4%
stock -11% · XLV -0%
matured Jan 3, 25
■ Hold neutral · not a buy · 🎯$37
Price at call : $32.33 — gap to target +14%
Today : $21.53 — gap to target +72%
🎯 on COLL : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Jan 3, 25
matures : Jan 3, 25
▲ Buy · 🎯$36
Price at call : $23.87 — upside +51%
Today : $21.53 — upside +67%
Expected +51% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+57.4%
stock +57% · XLV +16%
matured Aug 24, 24
HC Wainwright & Co. ↗
Aug 4, 23
■ Neutral neutral · not a buy
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Aug 3, 24
matures : Aug 3, 24
▲ Buy · 🎯$35
Price at call : $23.49 — upside +49%
Today : $21.53 — upside +63%
Expected +49% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+47.0%
stock +47% · XLV +11%
matured Aug 3, 24
▲ Buy · 🎯$35
Price at call : $21.8 — upside +61%
Today : $21.53 — upside +63%
Expected +61% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+52.3%
stock +52% · XLV +12%
matured May 29, 24
▲ Buy · 🎯$35
Price at call : $22.91 — upside +53%
Today : $21.53 — upside +63%
Expected +53% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+61.6%
stock +62% · XLV +6%
matured May 4, 24
▲ Buy · 🎯$35
Price at call : $22.88 — upside +53%
Today : $21.53 — upside +63%
Expected +53% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+52.0%
stock +52% · XLV +3%
matured Apr 18, 24
▲ Buy · 🎯$35
Price at call : $26.85 — upside +30%
Today : $21.53 — upside +63%
Expected +30% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+36.2%
stock +36% · XLV +14%
matured Feb 24, 24
▲ Buy · 🎯$35
Price at call : $26.71 — upside +31%
Today : $21.53 — upside +63%
Expected +31% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+25.4%
stock +25% · XLV +10%
matured Feb 8, 24
▲ Buy · 🎯$35
Price at call : $28.04 — upside +25%
Today : $21.53 — upside +63%
Expected +25% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+15.2%
stock +15% · XLV +3%
matured Jan 5, 24
▲ Buy · 🎯$34
Price at call : $18.84 — upside +80%
Today : $21.53 — upside +58%
Expected +80% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 79% (14 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+17.3%
stock +17% · XLV -2%
matured Nov 4, 23
HC Wainwright & Co. ↗
Aug 8, 22
■ Neutral neutral · not a buy
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Aug 8, 23
matures : Aug 8, 23
HC Wainwright & Co. ↗
Feb 15, 22
▲ Buy · 🎯$29
Price at call : $21.82 — upside +33%
Today : $21.53 — upside +35%
Expected +33% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+25.0%
stock +25% · XLV +1%
matured Feb 15, 23
HC Wainwright & Co. ↗
Aug 6, 21
▲ Buy · 🎯$28
Price at call : $20.54 — upside +36%
Today : $21.53 — upside +30%
Expected +36% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-5.1%
stock -5% · XLV -1%
matured Aug 6, 22
HC Wainwright & Co. ↗
Jan 11, 21
▲ Buy · 🎯$33
Price at call : $21.18 — upside +56%
Today : $21.53 — upside +53%
Expected +56% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-9.6%
stock -10% · XLV +16%
matured Jan 11, 22
HC Wainwright & Co. ↗
Nov 9, 20
▲ Buy · 🎯$29
Price at call : $20.38 — upside +42%
Today : $21.53 — upside +35%
Expected +42% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-0.3%
stock -0% · XLV +20%
matured Nov 9, 21
HC Wainwright & Co. ↗
Sep 11, 17
▲ Buy · 🎯$21
Price at call : $10.58 — upside +98%
Today : $21.53 — upside -2%
Expected +98% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on COLL : 56% (9 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+45.6%
stock +46% · XLV +11%
matured Sep 11, 18
Frequently asked questions
Should I buy Collegium Pharmaceutical, Inc. stock?
This isn't buy advice. For Collegium Pharmaceutical, Inc., the analyst consensus is "Buy", with an average price target of $47.00 (+118% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 71% of the time (21 calls tracked on Collegium Pharmaceutical, Inc.). We show the numbers — you decide.
Is it too late to buy Collegium Pharmaceutical, Inc.? How high can it go?
The most bullish analyst target on Collegium Pharmaceutical, Inc. is $50.00 (+132% above today's price); the average is $47.00. That's the upside they see. Check how reliable those analysts have actually been on Collegium Pharmaceutical, Inc. on our site before trusting it.
Is Collegium Pharmaceutical, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on Collegium Pharmaceutical, Inc., the best hitting 71% over 21 calls. Current consensus: "Buy". Make your call on data, not noise.
Will Collegium Pharmaceutical, Inc. stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will COLL stock recover (go back up)?
Should you invest in Collegium Pharmaceutical, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in COLL (and why hesitate).
What has Collegium Pharmaceutical, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: COLL performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX